Biogen : Strong progress toward three potential launches in

Strong progress toward three potential launches in 2023;


Company reports first quarter 2023 results and reaffirms full year 2023 guidance





First... | April 25, 2023

Related Keywords

China , Ukraine , Japan , Chuck Triano , Christophera Viehbacher , Adam Keeney , Jack Cox , Samsung Bioepis , Us Veteran Health Administration , Twitter , Biogen Inc , Advisory Committee , Facebook , Exchange Commission , Nasdaq , Head Of Corporate Development , Net Income Attributable To Biogen Inc , Development Expense , Linkedin , Youtube , Priority Review , Health Administration , Sage Therapeutics , Zuranolone New Drug Application , Investor Relations , Corporate Development , Chief Executive Officer Christopher , Total Revenue , Neurimmune Subone , Today Biogen , Remedy Pharmaceuticals , Three Months Ended March , Muscular Atrophy , Administrative Expense , Acquired Intangible Assets , Tax Rate , Noncontrolling Interests , Income Attributable , Earnings Per Share , World Revenue , Biosimilars Product Revenue , Contract Manufacturing , Biogen Inc Stock Exchange , News , Information , Press Release , Strong , Progress , Howard , Three , Potential , Aunches , N , Company , Reports , First , Quarter , 023 , Results , End , Eaffirms , Bull , Ear , 023 Biib Us09062x1037 ,